Debra A Wolff

Suggest Changes
Learn More
PURPOSE To evaluate the risk of acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) and overall mortality in patients receiving chemotherapy with or without granulocyte colony-stimulating(More)